ORAMED PHARMACEUTICALS INC (ORMP) Stock News
NASDAQ:ORMP - Nasdaq - US68403P2039 - Common Stock - Currency: USD
ORMP Latest News, Press Relases and Analysis
Unusual volume stocks in Wednesday's session
Discover the stocks with unexpected trading volume in today's session on the US markets.
What's going on in today's session
Keep an eye on the top gainers and losers in Tuesday's session, as they reflect the most notable price movements.
Oramed Announces Transformative Joint Venture to Accelerate Development and Commercialization of Oral Insulin
New Standalone Company, OraTech Pharmaceuticals Inc., to Focus on Oral Drug Delivery with Strategic Investment and Advanced Manufacturing Capabilities Oramed...
Oramed Pharmaceuticals Announces Restructuring of Scilex Holding Company Debt
/PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) ("Oramed"), a clinical-stage pharmaceutical company focused on the development of oral...
Mentions: SCLX
ORMP Stock Earnings: Oramed Pharmaceuticals Beats EPS for Q2 2024
ORMP stock results show that Oramed Pharmaceuticals beat analyst estimates for earnings per share the second quarter of 2024.
ORMP Stock Earnings: Oramed Pharmaceuticals Beats EPS for Q2 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Oramed Pharmaceuticals (NASDAQ:ORMP) just reported results for the second quart...
3 Micro-Cap Moonshots for Fearless Investors
Investors should know the risks of micro-cap stocks before looking into these three high-potential companies with low prices.
Oramed Letter to Shareholders
/PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) ("Oramed") (www.oramed.com), a clinical-stage pharmaceutical company focused on the...
Oramed Pharmaceuticals Inc. Announces the Buy-Back of its Common Stock
/PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (the "Company") (www.oramed.com), a clinical-stage pharmaceutical company focused on...
ORMP Stock Earnings: Oramed Pharmaceuticals Beats EPS for Q1 2024
ORMP stock results show that Oramed Pharmaceuticals beat analyst estimates for earnings per share the first quarter of 2024.
ORMP Stock Earnings: Oramed Pharmaceuticals Beats EPS for Q1 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Oramed Pharmaceuticals (NASDAQ:ORMP) just reported results for the first quarte...
ORMP Stock Earnings: Oramed Pharmaceuticals Beats EPS for Q4 2023
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Oramed Pharmaceuticals (NASDAQ:ORMP) just reported results for the fourth quart...
ORMP Stock Earnings: Oramed Pharmaceuticals Beats EPS for Q4 2023
ORMP stock results show that Oramed Pharmaceuticals beat analyst estimates for earnings per share the fourth quarter of 2023.
Oramed Letter to Shareholders
/PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of...
PhaseV Raises $15 Million to Push the Boundaries of ML for Clinical Trial Optimization
/PRNewswire/ -- PhaseV a pioneer in causal machine learning (ML) technology that optimizes clinical trial design and analysis, announced today that it has...
Sorrento Therapeutics, Inc. Announces the Consummation of the Previously Announced Sale of Substantially All of the Common Shares, Preferred Shares and Warrants that Sorrento Held in Scilex Holding Company
/PRNewswire/ -- Sorrento Therapeutics, Inc. (OTC: SRNEQ, "Sorrento" or "Company"), a biopharmaceutical company dedicated to the development of life-saving...
Mentions: SCLX
Oramed Announces $101,875,000 Short-Term Senior Secured Note Transaction with Scilex Holding Company
/PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE:ORMP) today announced that on September 21, 2023, Oramed and Scilex Holding Company ("Scilex")...
Oramed Signs Term Sheet with HTIT to Create a Joint Venture to Advance Oral Drug Delivery Technology Globally
/PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP) (www.oramed.com) announced today that it has signed a non-binding term sheet with Hefei...
Oramed to Present at the 83rd American Diabetes Association Conference
/PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com), announced today that it has been selected to present an oral abstract...
Oramed to Present at Novel Therapies for Type 2 Diabetes & Obesity Summit
/PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com), announced today that Chief Scientific Officer Dr. Miriam Kidron will...
Oramed's Chinese partner HTIT completes phase 3 oral insulin trial (NASDAQ:ORMP)
Oramed Pharmaceuticals (ORMP) has announced the successful completion of Phase 3 trials for oral insulin in type 2 diabetes in China by its strategic partner, Hefei Tianhui...
Oramed Announces that its Chinese Partner, HTIT, has Successfully Completed a Phase 3 Oral Insulin Clinical Trial and Submitted a Marketing Authorization Application in China
/PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com) announced today that Hefei Tianhui Biotechnology Co. Ltd. (HTIT), a...
Investing millions, Ben Shapiro joins board of Oramed Pharmaceuticals
Conservative political commentator and entrepreneur, Ben Shapiro, has taken a $4.7M stake in struggling Israeli pharmaceutical company Oramed Pharmaceuticals. Read more here.
Mentions: NYT
Conservative Pundit Ben Shapiro Invests $4.7 Million in Israeli Drug Company
Right-wing media entrepreneur Ben Shapiro has taken a $4.7 million stake in a struggling Israeli pharmaceutical company and joined the board.
Oramed Pharmaceuticals Issues Shareholder Update
/PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com), announced today that it continues to conduct a comprehensive analysis...